Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy

Acta Neurologica Scandinavica

Volumn 106, Issue 6, 2002, Pages 379-386

  Tha, Khin Khin ^a   Terae, S ^a   Sugiura, M ^a   Nishioka, T ^a   Oka, M ^a   Kudoh, K ^a   Kaneko, K ^a   Miyasaka, K ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

5 fluorouracil; Anisotropy; Diffusion; Leukoencephalopathy; Magnetic resonance imaging

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGITATION; ANISOTROPY; ARTICLE; CASE REPORT; COMA; CONFUSION; CONTRAST ENHANCEMENT; CORPUS CALLOSUM; DIAGNOSTIC IMAGING; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISORIENTATION; EARLY DIAGNOSIS; HEARING IMPAIRMENT; HUMAN; LEUKOENCEPHALOPATHY; MALE; MYELIN SHEATH; NEUROLOGIC DISEASE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT; SEIZURE; SOLID TUMOR; STUPOR; WHITE MATTER;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN; DEMENTIA, VASCULAR; DIFFUSION MAGNETIC RESONANCE IMAGING; FLUOROURACIL; HUMANS; MALE; TIME FACTORS;

EID: 0036917321     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2002.01253.x     Document Type: Article

References (21)

1. Dolley C. Therapeutic Drugs, Vol. 1. London: Churchill Livingstone, 1991;F68-73.
2. Pirzada NA, Ali II, Dafer RM. Fluorouracil-induced neurotoxicity. Ann Pharmacother 2000;34:35-8.
3. Lynch HT, Droszcz CP, Albano WA, Lynch JF. Organic brain syndrome secondary to 5-fluorouracil toxicity. Dis Colon Rectum 1981;24:130-1.
4. Yeh KH. High-dose 5-fluorouracil tnfusional therapy is associated with hyperammonemia, lactic acidosis and encephalopathy. Br J Cancer 1997;75:464-5.
5. Matsumoto S, Nishizawa S, Murakami M, Noma S, Sano A, Kuroda Y. Carmofur-induced Leukoencephalopathy. MRI Neuroradiol 1995;37:649-52.
6. Choi SM, Lee SH, Yang YS, Kim BC, Kim MK, Cho KH. 5-Fluorouracil-induced leukoencephalopathy in patients with breast cancer. J Korean Med Sci 2001;16:328-34.
7. Nomura K, Ohno R, Hamaguchi K, Hata T, Hatanaka H, Matsuyama H. Clinicopathological report of cisplatin encephalopathy. Rinsho Shinkeigaku 1995;35:64-9.
8. Itou Y, Arahata Y, Goto Y, Hirayama M et al. Cisplatin neurotoxicity presenting as reversible leukoencephalopathy syndrome. AJNR 1998;19:415-7.
9. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000; 217:331-45.
10. Schaefer PW, Buonanno FS, Gonzalea RG, Schwamm LH. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997;28:1082-5.
11. Hayashi R, Hanyu N, Kitahara A. Leukoencephalopathy induced by Tegafur: Serial studies of somatosensory evoked potentials and cerebrospinal fluid. Intern Med 1992;31:828-33.
12. Ohara S, Hayashi R, Hata S, Itoh N, Hanyu N, Yamamoto K. Leukoencephalopathy induced by chemotherapy with Tegafur, a 5-fluorouracil derivative. Acta Neropathol 1998;96:527-31.
13. Akiba T, Okeda R, Tajima T. Metabolites of 5-fluorouracil, α-fluoro-α-alanine and fluoroacetic acid, directly injure myelinated fibers in tissue culture. Acta Neuropathol 1996;92:8-13.
14. Okeda R, Karakama T, Kimura S et al. Neuropathologic Study on chronic neurotoxicity of 5-fluorouracil and its masked compounds in dog. Acta Neuropathol (Berl) 1984;63:331-43.
15. Okeda R, Shibutani M, Matsuo T, Kuroiwa T. Subacute neurotoxicity of 5-flurouracil and its derivative, carmofur, in cats. Acta Pathol Jpn 1988;38:1255-66.
16. Hanyu H, Asano T, Sakurai H et al. Diffusion-weighted magnetization transfer imaging corpus callosum Alzeimer's. Dis J Neurol Sci 1999;167:37-44.
17. Maldjian JA, Grossman RI. Future applications of DWI in MS. J Neurol Sci 2001;186:S55-S57.
18. Foong J, Maier M, Clark CA, Barker GJ, Miller DH, Ron MA. Neurological abnormalities of the corpus callosum in Schizophrenia: A Diffusion Tensor Imaging Study. J Neurol Neurosurg Psychiatry 2000;68:242-4.
19. Cheng-Yu C, Kwo-Wei L, Chueng-Chen L, Shy-Chi C, Hsiao-Wen C, Robert A. Zimmerman. Heroin-induced spongiform leukoencephalopathy. Value diffusion MR imaging. J Comp Assisted Tomogr 2000;24:735-7.
20. Fujikawa A, Tsuchira K, Katase S, Kurosaki Y, Hachiya J. Diffusion-weighted MR Imaging of carmofur-induced leukoencephalopathy. Eur Radiol 2001;11:2602-6.
21. Provenzale JM, Engelter ST, Petrella JR, Smith JS, MacFall JR. Use of MR exponential diffusion-weighted images to eradicate T2 'Shine-Through' effect. AJR 1999;172:537-9.